PatientsVille.com Logo

PatientsVille

Pegatron Side Effects

Common Pegatron Side Effects


The most commonly reported Pegatron side effects (click to view or check a box to report):

Influenza Like Illness (6)
Chest Pain (6)
Eczema (6)
Pruritus (5)
Rash (5)
Headache (4)
Epistaxis (4)
Dyspnoea (4)
Cholelithiasis (4)
Disorientation (4)
Septic Shock (4)
Vision Blurred (4)
Multi-organ Failure (4)
Hypertension (4)
Pain (4)
Pneumonia (4)
Dehydration (3)
Emotional Disorder (3)
Injection Site Infection (3)
Nausea (3)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Pegatron Side Effects Reported to FDA

The following Pegatron reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Pegatron on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Intentional Overdose, Rash, Gastrooesophageal Reflux Disease, Herpes Virus Infection, Orthostatic Hypotension, Dizziness, No Therapeutic Response, Treatment Noncompliance
This is a report of a 60-year-old female patient (weight: NA) from AU, suffering from the following symptoms/conditions: hepatitis c, who was treated with Pegatron (dosage: Unk, start time: Jul 31, 2013), combined with:
  • Boceprevir
  • Ribavirin (Unk)
  • Desvenlafaxine (Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Intentional Overdose
  • Rash
  • Gastrooesophageal Reflux Disease
  • Herpes Virus Infection
  • Orthostatic Hypotension
  • Dizziness
  • No Therapeutic Response
  • Treatment Noncompliance
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Pegatron treatment in female patients, resulting in intentional overdose side effect.

Pneumonia
This report suggests a potential Pegatron Pneumonia side effect(s) that can have serious consequences. A 50-year-old female patient (weight: NA) from AU was diagnosed with the following symptoms/conditions: hepatitis c and used Pegatron (dosage: 180 Microgram, Qw) starting Oct 04, 2013. Soon after starting Pegatron the patient began experiencing various side effects, including:
  • Pneumonia
Drugs used concurrently:
  • Rebetol (Unk)
  • Amitriptyline Hydrochloride (Unk)
The patient was hospitalized. Although Pegatron demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as pneumonia, may still occur.

Pneumonia Haemophilus
This Pneumonia Haemophilus problem was reported by a health professional from AU. A 49-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hepatitis c. On Apr 03, 2013 this consumer started treatment with Pegatron (dosage: 150 Microgram,qw). The following drugs were being taken at the same time: NA. When commencing Pegatron, the patient experienced the following unwanted symptoms/side effects:
  • Pneumonia Haemophilus
The patient was hospitalized and became disabled.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pneumonia haemophilus, may become evident only after a product is in use by the general population.

Syncope, Confusional State, Vomiting, Diarrhoea, Arthralgia, Somnolence, Unresponsive To Stimuli, Headache
This is a report of a 54-year-old male patient (weight: NA) from AU. The patient developed the following symptoms/conditions: antiviral treatment and was treated with Pegatron (dosage: 150 Mg, Unk) starting 201305. Concurrently used drugs:
  • Ribavirin (1200 Mg, Unk)
  • Citalopram (20 Mg, Unk)
Soon after that, the consumer experienced the following side effects:
  • Syncope
  • Confusional State
  • Vomiting
  • Diarrhoea
  • Arthralgia
  • Somnolence
  • Unresponsive To Stimuli
  • Headache
The patient was hospitalized. This opens a possibility that Pegatron treatment could cause the above reactions, including syncope, and some male subjects may be more susceptible.


Abdominal Pain, Febrile Neutropenia, Rash Papular
A 53-year-old female patient (weight: NA) from AU with the following symptoms/conditions: hepatic cirrhosis started Pegatron treatment (dosage: 1 Df, Unk) on 2012. Soon after starting Pegatron treatment, the subject experienced various side effects, including:
  • Abdominal Pain
  • Febrile Neutropenia
  • Rash Papular
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Pegatron.

Subarachnoid Haemorrhage, Surgery
A 56-year-old female patient from AU (weight: NA) experienced symptoms, such as: hepatitis c and was treated with Pegatron(dosage: Unk). The treatment was initiated on 201210. After that a consumer reported the following side effect(s):
  • Subarachnoid Haemorrhage
  • Surgery
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Pegatron efficacy:
  • Ribavirin (Unk)
  • Metformin
  • Aspirin
  • Metoclopramide
  • Venlafaxine Hydrochloride
The patient was hospitalized.

Dehydration, Hypotension, Malaise, Epistaxis, Rectal Haemorrhage, Gingival Bleeding, Platelet Count Decreased
In this report, Pegatron was administered for the following condition: hepatitis c.A 56-year-old male consumer from AU (weight: NA) started Pegatron treatment (dosage: Unk) on 2012.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Dehydration
  • Hypotension
  • Malaise
  • Epistaxis
  • Rectal Haemorrhage
  • Gingival Bleeding
  • Platelet Count Decreased
A possible interaction with other drugs could have contributed to this reaction:
  • Victrelis 200 Mg (Unk)
  • Mirtazapine Dp
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Pegatron treatment could be related to the listed above side effect(s).

Abdominal Pain
This is a report of the following Pegatron (pegylated Interferon Alfa-2b W/ribavirin) side effect(s):
  • Abdominal Pain
A 53-year-old female patient from AUSTRALIA (weight: NA) presented with the following condition: hepatitis c and received a treatment with Pegatron (pegylated Interferon Alfa-2b W/ribavirin) (dosage: NA) starting: NS.The following concurrently used drugs could have generated interactions:
  • Victrelis
The patient was hospitalized.This report suggests that a Pegatron (pegylated Interferon Alfa-2b W/ribavirin) treatment could be associated with the listed above side effect(s).

Dyspnoea, Wolff-parkinson-white Syndrome, Emotional Disorder, Rash, Arterial Occlusive Disease
This Pegatron (pegylated Interferon Alfa-2b W/ribavirin) report was submitted by a 36-year-old male consumer from AUSTRALIA (weight: NA). The patient was diagnosed with: hepatitis c and Pegatron (pegylated Interferon Alfa-2b W/ribavirin) was administered (dosage: NA) starting: Sep 27, 2011. The consumer developed a set of symptoms:
  • Dyspnoea
  • Wolff-parkinson-white Syndrome
  • Emotional Disorder
  • Rash
  • Arterial Occlusive Disease
Other drugs used simultaneously: NA.The patient was hospitalized.Those unexpected symptoms could be linked to a Pegatron (pegylated Interferon Alfa-2b W/ribavirin) treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Influenza Like Illness, Lethargy, Dyspnoea Exertional, Rash, Headache, Arterial Occlusive Disease, Psoriasis, Emotional Disorder, Cold Sweat
This is a report of a possible correlation between Pegatron (pegylated Interferon Alfa-2b W/ Ribavirin) use and the following symptoms/side effect(s):
  • Influenza Like Illness
  • Lethargy
  • Dyspnoea Exertional
  • Rash
  • Headache
  • Arterial Occlusive Disease
  • Psoriasis
  • Emotional Disorder
  • Cold Sweat
which could contribute to an assessment of Pegatron (pegylated Interferon Alfa-2b W/ Ribavirin) risk profile.A 36-year-old male consumer from AUSTRALIA (weight: NA) was suffering from hepatitis c and was treated with Pegatron (pegylated Interferon Alfa-2b W/ Ribavirin) (dosage: NA) starting Sep 27, 2011.Other concurrent medications: NA.The patient was hospitalized.

Multi-organ Failure, Pneumonia Staphylococcal, Hepatic Failure, Metabolic Acidosis, Continuous Haemodiafiltration, Dialysis, Septic Shock
A 57-year-old female patient from AUSTRALIA (weight: NA) presented with the following symptoms: hepatitis c and after a treatment with Pegatron (pegylated Interferon Alfa-2b W/ribavirin) (dosage: 100 Mcg;qw) experienced the following side effect(s):
  • Multi-organ Failure
  • Pneumonia Staphylococcal
  • Hepatic Failure
  • Metabolic Acidosis
  • Continuous Haemodiafiltration
  • Dialysis
  • Septic Shock
The treatment was started on Dec 01, 2011. Pegatron (pegylated Interferon Alfa-2b W/ribavirin) was used in combination with the following drugs:
  • Boceprevir (sch-503034) (800 Mg;tid)
The patient was hospitalized.This report could alert potential Pegatron (pegylated Interferon Alfa-2b W/ribavirin) consumers.

Impaired Healing, Injection Site Necrosis, Platelet Count Decreased, Injection Site Infection
In this report, a 51-year-old male patient from AUSTRALIA (weight: NA) was affected by a possible Pegatron (pegylated Interferon Alfa-2b W/ribavirin) side effect.The patient was diagnosed with hepatic cirrhosis,hepatitis c. After a treatment with Pegatron (pegylated Interferon Alfa-2b W/ribavirin) (dosage: Qw;sc, start date: Aug 13, 2010), the patient experienced the following side effect(s):
  • Impaired Healing
  • Injection Site Necrosis
  • Platelet Count Decreased
  • Injection Site Infection
The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Pegatron (pegylated Interferon Alfa-2b W/ribavirin) treatment.

Hyperhidrosis, Thirst, Cholecystitis Infective, Headache, Cholelithiasis, Gallbladder Operation, Influenza Like Illness, Pain
This is a report of a 49-year-old male patient from AUSTRALIA (weight: NA), who used Pegatron (pegylated Interferon Alfa-2b W/ribavirin) (dosage: NA) for a treatment of hepatitis c. After starting a treatment on Jul 07, 2011, the patient experienced the following side effect(s):
  • Hyperhidrosis
  • Thirst
  • Cholecystitis Infective
  • Headache
  • Cholelithiasis
  • Gallbladder Operation
  • Influenza Like Illness
  • Pain
The following drugs could possibly have interacted with the Pegatron (pegylated Interferon Alfa-2b W/ribavirin) treatment NA.The patient was hospitalized.Taken together, these observations suggest that a Pegatron (pegylated Interferon Alfa-2b W/ribavirin) treatment could be related to side effect(s), such as Hyperhidrosis, Thirst, Cholecystitis Infective, Headache, Cholelithiasis, Gallbladder Operation, Influenza Like Illness, Pain.

Cholelithiasis, Cholecystitis Infective, Influenza Like Illness, Pain, Hyperhidrosis, Headache
This cholelithiasis side effect was reported by a health professional from AUSTRALIA. A 49-year-old male patient (weight:NA) experienced the following symptoms/conditions: hepatitis c. The patient was prescribed Pegatron (pegylated Interferon Alfa-2b W/ribavirin) (dosage: NA), which was started on Jul 07, 2011. Concurrently used drugs: NA. When starting to take Pegatron (pegylated Interferon Alfa-2b W/ribavirin) the consumer reported the following symptoms:
  • Cholelithiasis
  • Cholecystitis Infective
  • Influenza Like Illness
  • Pain
  • Hyperhidrosis
  • Headache
The patient was hospitalized. These side effects may potentially be related to Pegatron (pegylated Interferon Alfa-2b W/ribavirin).

Feeling Abnormal, Haematemesis, Influenza Like Illness
This is a Pegatron (pegylated Interferon Alfa-2b W/ribavirin) side effect report of a 50-year-old male patient (weight:NA) from AUSTRALIA, suffering from the following symptoms/conditions: NA, who was treated with Pegatron (pegylated Interferon Alfa-2b W/ribavirin) (dosage:NA, start time: May 09, 2011), combined with: NA., and developed a serious reaction and a feeling abnormal side effect. The patient presented with:
  • Feeling Abnormal
  • Haematemesis
  • Influenza Like Illness
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Pegatron (pegylated Interferon Alfa-2b W/ribavirin) treatment in male patients suffering from NA, resulting in feeling abnormal.

Necrosis, Injection Site Infection, Injection Site Erythema, Injection Site Pain
This report suggests a potential Pegatron (pegylated Interferon Alfa-2b W/ribavirin) necrosis side effect(s) that can have serious consequences. A 51-year-old male patient from AUSTRALIA (weight:NA) was diagnosed with the following health condition(s): hepatitis c,hepatic cirrhosis and used Pegatron (pegylated Interferon Alfa-2b W/ribavirin) (dosage: Qw, Sc) starting Aug 13, 2010. Soon after starting Pegatron (pegylated Interferon Alfa-2b W/ribavirin) the patient began experiencing various side effects, including:
  • Necrosis
  • Injection Site Infection
  • Injection Site Erythema
  • Injection Site Pain
Drugs used concurrently:NA. Although Pegatron (pegylated Interferon Alfa-2b W/ribavirin) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as necrosis, may still occur.

Dry Skin, Cerebral Haemorrhage, Pruritus, Epistaxis, Influenza Like Illness, Rash
This dry skin problem was reported by a health professional from AUSTRALIA. A 44-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): hepatitis c.On Aug 11, 2010 a consumer started treatment with Pegatron (pegylated Interferon Alfa-2b W/ Ribavirin) (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Pegatron (pegylated Interferon Alfa-2b W/ Ribavirin), the patient experienced the following unwanted symptoms /side effects:
  • Dry Skin
  • Cerebral Haemorrhage
  • Pruritus
  • Epistaxis
  • Influenza Like Illness
  • Rash
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as dry skin, may become evident only after a product is in use by the general population.

Influenza Like Illness, Rash, Epistaxis, Fatigue, Dry Skin, Pruritus
This is a Pegatron (pegylated Interferon Alfa-2b W/ Ribavirin) side effect report of a 44-year-old male patient (weight: NA) from AUSTRALIA. The patient developed the following symptoms/conditions: hepatitis c and was treated with Pegatron (pegylated Interferon Alfa-2b W/ Ribavirin) (dosage: NA) starting Aug 11, 2010. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Influenza Like Illness
  • Rash
  • Epistaxis
  • Fatigue
  • Dry Skin
  • Pruritus
This opens a possibility that Pegatron (pegylated Interferon Alfa-2b W/ Ribavirin) could cause influenza like illness and that some male patients may be more susceptible.

Kidney Infection, Injection Site Pain, Septic Embolus, Injection Site Infection, Injection Site Erythema, Injection Site Scab
A 26-year-old female patient (weight: NA) from AUSTRALIA with the following symptoms: hepatitis c started Pegatron (pegylated Interferon Alfa-2b W/ribavirin treatment (dosage: NA) on Apr 02, 2010. Soon after starting Pegatron (pegylated Interferon Alfa-2b W/ribavirin treatment, the consumer experienced several side effects, including:
  • Kidney Infection
  • Injection Site Pain
  • Septic Embolus
  • Injection Site Infection
  • Injection Site Erythema
  • Injection Site Scab
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Pegatron (pegylated Interferon Alfa-2b W/ribavirin side effects, such as kidney infection.

Pericarditis
This pericarditis side effect was reported by a health professional from AUSTRALIA. A 44-year-old male patient (weight:NA) experienced the following symptoms/conditions: hepatitis c.The patient was prescribed Pegatron (pegylated Interferon Alfa-2b W/ribavirin) (dosage: NA), which was started on NS. Concurrently used drugs: NA..When starting to take Pegatron (pegylated Interferon Alfa-2b W/ribavirin) the consumer reported symptoms, such as:
  • Pericarditis
These side effects may potentially be related to Pegatron (pegylated Interferon Alfa-2b W/ribavirin). The patient was hospitalized.

Kidney Infection, Septic Embolus
This is a report of a 26-year-old female patient (weight: NA) from AUSTRALIA, suffering from the following symptoms/conditions: hepatitis c, who was treated with Pegatron (pegylated Interferon Alfa-2b W/ribavirin) (dosage: NA, start time: Apr 02, 2010), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Kidney Infection
  • Septic Embolus
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Pegatron (pegylated Interferon Alfa-2b W/ribavirin) treatment in female patients, resulting in kidney infection side effect. The patient was hospitalized.

Radiculitis Brachial
This report suggests a potential Pegatron (pegylated Interferon Alfa-2b W/ribavirin) Radiculitis Brachial side effect(s) that can have serious consequences. A 53-year-old female patient (weight: NA) from AUSTRALIA was diagnosed with the following symptoms/conditions: NA and used Pegatron (pegylated Interferon Alfa-2b W/ribavirin) (dosage: NA) starting NS. Soon after starting Pegatron (pegylated Interferon Alfa-2b W/ribavirin) the patient began experiencing various side effects, including:
  • Radiculitis Brachial
Drugs used concurrently: NA.The patient was hospitalized. Although Pegatron (pegylated Interferon Alfa-2b W/ribavirin) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as radiculitis brachial, may still occur.

Pericarditis
This Pericarditis problem was reported by a health professional from AUSTRALIA. A 44-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Pegatron (pegylated Interferon Alfa-2b W/ Ribavirin) (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Pegatron (pegylated Interferon Alfa-2b W/ Ribavirin), the patient experienced the following unwanted symptoms/side effects:
  • Pericarditis
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pericarditis, may become evident only after a product is in use by the general population.

Cataract
This is a report of a 54-year-old male patient (weight: NA) from AUSTRALIA. The patient developed the following symptoms/conditions: hepatitis c and was treated with Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf (dosage: NA) starting Jun 01, 2009. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Cataract
This opens a possibility that Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf treatment could cause the above reactions, including cataract, and some male subjects may be more susceptible.

Abasia, Anal Haemorrhage, Haemorrhoids, Hypokinesia
A 54-year-old male patient (weight: NA) from AUSTRALIA with the following symptoms/conditions: hepatitis c started Pegatron (peginteferon Alfa-2b W/ribavirin) (pegylated Interferon Alfa treatment (dosage: NA) on Apr 07, 2009. Soon after starting Pegatron (peginteferon Alfa-2b W/ribavirin) (pegylated Interferon Alfa treatment, the subject experienced various side effects, including:
  • Abasia
  • Anal Haemorrhage
  • Haemorrhoids
  • Hypokinesia
Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Pegatron (peginteferon Alfa-2b W/ribavirin) (pegylated Interferon Alfa.

1 of 3 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Pegatron Side Effects

    Did You Have a Pegatron Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Pegatron for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Pegatron Safety Alerts, Active Ingredients, Usage Information

    More About Pegatron

    Side Effects reported to FDA: 63

    Pegatron safety alerts: No

    Reported deaths: 5

    Reported hospitalizations: 23

    Latest Pegatron clinical trials